Liver functions in patients with obstructive sleep apnea syndrome
Objective: Previous studies showed that obstructive sleep apnea syndrome (OSAS) was associated with liver diseases such as elevated liver enzyme levels and hepatic steatosis. The aim of this study was to assess the relationship between serum aspartate aminotransferase (AST) and alanine aminotransfer...
Saved in:
Published in | The European research journal Vol. 4; no. 4; pp. 349 - 355 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Bursa
The Association of Health Research & Strategy
04.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective: Previous studies showed that
obstructive sleep apnea syndrome (OSAS) was associated with liver diseases such
as elevated liver enzyme levels and hepatic steatosis. The
aim of this study was to assess the relationship between serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and
OSAS and its severity. Methods: A total of 617 patients who underwent PSG (polysomnography) between January 2016
and May 2017 were evaluated in this study. AST, ALT, total cholesterol,
triglyceride levels and body mass index were analyzed.
The data were analyzed using the Student t-test, ANOVA, Chi-square test, and Pearson's
correlation coefficient. Results: Five hundreds and thirty
patients with OSAS and 60 healthy controls were included in the study. Of the
patients in the OSAS group, 17.7% had an elevated ALT level and 7.9% had an
elevated AST level. There was a statistically significant difference in ALT and
AST levels between the OSAS and control groups (p < 0.001 and p < 0.001,
respectively). In the OSAS group, there was a statistically significant
positive relationship between serum ALT and AST levels and apnea-hypopnea index
(AHI), apnea index, oxygen desaturation index. Both AST and ALT levels were
statistically significantly higher in obese patients than in non-obese patients
(p < 0.001 and p < 0.001, respectively). ALT level
was statistically significantly higher in patients without hypertension than in
patients with hypertension (p < 0.001).
In OSAS patients without hypertension, there was a statistically significant
relationship between serum ALT and AST levels and AHI (r = 0.223, p < 0.001 and r = 0.142, p = 0.007; respectively). Conclusion:
OSAS is a risk factor for elevated liver enzyme
levels. Hypoxia plays an important role on liver enzymes in OSAS patients. |
---|---|
ISSN: | 2149-3189 2149-3189 |
DOI: | 10.18621/eurj.381906 |